Digital therapeutics as an emerging new therapy for diabetes mellitus: potentials and concerns
- PMID: 38963663
- PMCID: PMC11378137
- DOI: 10.1530/EC-24-0219
Digital therapeutics as an emerging new therapy for diabetes mellitus: potentials and concerns
Abstract
The global burden of controlling and managing diabetes mellitus (DM) is a significant challenge. Despite the advancements in conventional DM therapy, there remain hurdles to overcome, such as enhancing medication adherence and improving patient prognosis. Digital therapeutics (DTx), an innovative digital application, has been proposed to augment the traditional disease management workflow, particularly in managing chronic diseases like DM. Several studies have explored DTx, yielding promising results. However, certain concerns about this innovation persist. In this review, we aim to encapsulate the potential of DTx and its applications in DM management, thereby providing a comprehensive overview of this technique for public health policymakers.
Keywords: diabetes; diabetes management; digital health; digital technology; digital therapeutics.
Conflict of interest statement
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the study reported.
Figures
Similar articles
-
Changing face of healthcare: digital therapeutics in the management of diabetes.Curr Med Res Opin. 2021 Dec;37(12):2089-2091. doi: 10.1080/03007995.2021.1976737. Epub 2021 Sep 23. Curr Med Res Opin. 2021. PMID: 34511002
-
Benchmarking the clinical outcomes of Healthentia SaMD in chronic disease management: a systematic literature review comparison.Front Public Health. 2024 Dec 24;12:1488687. doi: 10.3389/fpubh.2024.1488687. eCollection 2024. Front Public Health. 2024. PMID: 39776481 Free PMC article.
-
A comprehensive survey of the clinical trial Landscape on digital therapeutics.Heliyon. 2024 Aug 10;10(16):e36115. doi: 10.1016/j.heliyon.2024.e36115. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39224386 Free PMC article.
-
Digital therapeutics in Korea: current status, challenges, and future directions - a narrative review.J Yeungnam Med Sci. 2025;42:8. doi: 10.12701/jyms.2024.01004. Epub 2024 Nov 18. J Yeungnam Med Sci. 2025. PMID: 39551075 Free PMC article.
-
Digital therapeutics in Japan: Present and future directions.J Cardiol. 2025 May;85(5):360-365. doi: 10.1016/j.jjcc.2024.11.005. Epub 2024 Nov 28. J Cardiol. 2025. PMID: 39613155 Review.
Cited by
-
Approved trends and product characteristics of digital therapeutics in four countries.NPJ Digit Med. 2025 May 26;8(1):308. doi: 10.1038/s41746-025-01660-9. NPJ Digit Med. 2025. PMID: 40419648 Free PMC article.
References
-
- Patterson CC Karuranga S Salpea P Saeedi P Dahlquist G Soltesz G & Ogle GD. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice, 2019157107842. ( 10.1016/j.diabres.2019.107842) - DOI - PubMed
-
- Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice 2022183109119. ( 10.1016/j.diabres.2021.109119) - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources